Pancreatic Cancer Resectable Clinical Trials

36 clinical trials for Pancreatic Cancer Resectable across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pancreatic Cancer Detection Consortium — RECRUITING
• Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer — RECRUITING
• Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer — RECRUITING · PHASE1
• Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery — RECRUITING · NA
• Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer — RECRUITING · PHASE3
• French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) — RECRUITING
• Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure — RECRUITING · NA
• Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy — RECRUITING
• Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer — RECRUITING · PHASE2
• The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer — RECRUITING · PHASE4
• Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID) — ACTIVE_NOT_RECRUITING
• Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases — NOT_YET_RECRUITING
• EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) — NOT_YET_RECRUITING · NA
• Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma — ACTIVE_NOT_RECRUITING
• Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer — NOT_YET_RECRUITING · PHASE2
• Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers — COMPLETED
• Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer — ACTIVE_NOT_RECRUITING
• Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer — NOT_YET_RECRUITING · PHASE3
• Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer — NOT_YET_RECRUITING
• Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer. — NOT_YET_RECRUITING · PHASE1
• Neoadjuvant Chemotherapy for Elderly with Pancreatic Head Cancer — NOT_YET_RECRUITING
• Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer — COMPLETED
• Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers — NOT_YET_RECRUITING · NA
• Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography — NOT_YET_RECRUITING
• Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures — NOT_YET_RECRUITING
• EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial) — OTHER · NA
• Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head — NOT_YET_RECRUITING · PHASE2
• Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients. — COMPLETED · PHASE2
• Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors — OTHER · PHASE2
• Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma — COMPLETED
• Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms — OTHER · PHASE1
• Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid — OTHER
• Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer — TERMINATED · PHASE2

Refine this search